Login / Signup

Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis.

Ping YangQing-Qing CaiWei ZhangShuo-Zi LiuHui LiuXiu-Hua SunYu-Jun DongXiu-Bin XiaoJing-Wen WangZhen-Ling LiWen-Rong HuangLi-Hong LiHui-Zheng BaoWei YangYa-Lan WangShu-Ye WangJuan HeXiao-Ling LiAi-Chun LiuHong-Mei Jing
Published in: Cancer medicine (2023)
First-line high dose cytarabine exposure, auto-SCT as consolidation therapy obtained survival benefits in Chinese population. Our study further confirmed the value of maintenance treatment and explored the application of new drug treatment and bendamustine in R/R MCL patients.
Keyphrases
  • high dose
  • emergency department
  • clinical trial
  • low dose
  • combination therapy
  • stem cells
  • cross sectional
  • chronic kidney disease
  • adverse drug
  • drug induced